From May 17, 2022 to June 30, 2022, the company has repurchased 5,135,800 shares, representing 1.05% for CNY 49.87 million. With this, the company has completed the repurchase of 5,135,800 shares, representing 1.05% for CNY 49.87 million under the buyback announced on May 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.92 CNY | +1.28% | -8.12% | +7.46% |
25/04 | Guangdong VTR Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
25/04 | Guangdong VTR Bio-Tech Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+7.46% | 519M | |
+18.15% | 12.02B | |
+12.88% | 6.21B | |
+3.98% | 5.42B | |
+13.78% | 5.13B | |
-17.79% | 2.74B | |
+3.80% | 1.95B | |
-6.80% | 1.29B | |
-8.29% | 958M | |
-16.58% | 946M |
- Stock Market
- Equities
- 300381 Stock
- News Guangdong VTR Bio-Tech Co., Ltd.
- Tranche Update on Guangdong VTR Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 18, 2022.